More than 1,800 employees at the Bern facility develop and manufacture innovative biotherapies derived from human plasma.
We are strategically locating our R&D capabilities in the greater Zurich biotech ecosystem.
We are proud to work in the field of rare and serious diseases and to provide therapy in many areas of treatment.
We also aim to make sure that nothing holds you back from getting the therapies you need.
CSL supports Investigator-Initiated Studies (IIS) that advance medical and scientific knowledge of CSL Behring products and the diseases they treat.
Every day at CSL Behring, we work as if someone's life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Popular search terms:
Download: Programm Access to the webinar: Link
Video Modal - Coming Soon
Insider Email Validation - Coming Soon
Cookie Policy Banner - Coming Soon
